TrialAnnals of the rheumatic diseases2013
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis.
Gerd R Burmester et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
96 papers cite itlatest 60 shown
this paperpooled ittrialcites it